• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腰椎穿刺在阿尔茨海默病中的应用及安全性建议:通俗易懂的概述。

The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary.

机构信息

Eisai Inc., Neurology Business Group, Nutley, New Jersey, USA.

Perelman School of Medicine, Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

Neurodegener Dis Manag. 2022 Oct;12(5):221-229. doi: 10.2217/nmt-2022-0012. Epub 2022 Jul 22.

DOI:10.2217/nmt-2022-0012
PMID:35866715
Abstract

WHAT IS THIS SUMMARY ABOUT?: This is a plain language summary of an article published in . It looks at a type of test called a lumbar puncture (also known as spinal tap) used in people suspected of having Alzheimer's disease or some other form of dementia. This summary focuses on how to do a lumbar puncture safely.

WHY IS THIS IMPORTANT?: Alzheimer's disease is a progressive condition, which means it gets worse over time. This leads to difficulties with thinking and memory. People with Alzheimer's disease show a build up of proteins called amyloid-β and tau in the brain. This is followed by a gradual loss of brain cells and brain function. The changes in the brain are thought to occur years before symptoms appear. Lumbar puncture is a medical procedure during which samples of cerebrospinal fluid are collected. In Alzheimer's disease, it is used to examine cerebrospinal fluid biomarkers that can help diagnose disease. Lumbar puncture is traditionally considered as a painful and invasive procedure with frequent side effects. However, multiple studies indicate that a lumbar puncture can be performed safely. Side effects are typically mild and do not require specialist intervention.

WHAT ARE THE KEY TAKEAWAYS?: Despite the low risk of serious complications associated with a lumbar puncture, physicians and their patients may be reluctant to recommend or undergo this procedure. Patient education, specialist training, as well as new methods concerning patient safety are important factors to support the widespread use of lumbar puncture in Alzheimer's disease.

摘要

这是一篇发表在[期刊名称]上的文章的通俗语言摘要。它探讨了一种称为腰椎穿刺(也称为脊髓穿刺)的测试方法,用于怀疑患有阿尔茨海默病或其他形式痴呆症的人群。本文重点关注如何安全地进行腰椎穿刺。

为什么这很重要?阿尔茨海默病是一种进行性疾病,随着时间的推移会逐渐恶化。这会导致思维和记忆方面的困难。患有阿尔茨海默病的人在大脑中会积聚称为淀粉样β和tau 的蛋白质。随后,脑细胞和脑功能逐渐丧失。据认为,大脑的这些变化在出现症状之前的多年就已经发生。腰椎穿刺是一种采集脑脊液样本的医疗程序。在阿尔茨海默病中,它用于检查有助于诊断疾病的脑脊液生物标志物。腰椎穿刺传统上被认为是一种痛苦且具有侵入性的程序,经常会产生副作用。但是,多项研究表明,可以安全地进行腰椎穿刺。副作用通常较轻,不需要专业干预。

有哪些主要收获?尽管与腰椎穿刺相关的严重并发症的风险较低,但医生及其患者可能不愿意推荐或进行此程序。患者教育、专家培训以及有关患者安全的新方法是支持在阿尔茨海默病中广泛使用腰椎穿刺的重要因素。

相似文献

1
The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary.腰椎穿刺在阿尔茨海默病中的应用及安全性建议:通俗易懂的概述。
Neurodegener Dis Manag. 2022 Oct;12(5):221-229. doi: 10.2217/nmt-2022-0012. Epub 2022 Jul 22.
2
The AT(N) system for describing biological changes in Alzheimer's disease: a plain language summary.用于描述阿尔茨海默病生物学变化的AT(N)系统:简明概述
Neurodegener Dis Manag. 2022 Oct;12(5):231-239. doi: 10.2217/nmt-2022-0013. Epub 2022 Jul 22.
3
Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain.在西班牙进行的一项多中心研究:腰椎穿刺在阿尔茨海默病脑脊液生物标志物研究中的可行性。
J Alzheimers Dis. 2014;39(4):719-26. doi: 10.3233/JAD-131334.
4
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.腰椎穿刺在唐氏综合征患者阿尔茨海默病脑脊液生物标志物研究中的可行性
J Alzheimers Dis. 2017;55(4):1489-1496. doi: 10.3233/JAD-160827.
5
Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes.临床正常压力脑积水患者的并发阿尔茨海默病病理学:大量腰椎穿刺结果、皮质脑活检及预后的相关性
J Neurosurg. 2016 Feb;124(2):382-8. doi: 10.3171/2015.2.JNS142318. Epub 2015 Sep 4.
6
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
7
Association between Longitudinal Cerebrospinal Fluid Alzheimer's Biomarkers and the Lifestyle for Brain Health (LIBRA) Index: Findings from the European Prevention of Alzheimer's Dementia Cohort Study (EPAD LCS).纵向脑脊液阿尔茨海默病生物标志物与大脑健康生活方式(LIBRA)指数之间的关联:来自欧洲预防阿尔茨海默病痴呆症队列研究(EPAD LCS)的结果。
J Prev Alzheimers Dis. 2023;10(3):543-550. doi: 10.14283/jpad.2023.31.
8
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
9
A study of once-a-week donepezil transdermal system's bioequivalence to oral donepezil in healthy volunteers: a plain language summary.一项关于每周一次透皮多奈哌齐与口服多奈哌齐在健康志愿者中生物等效性的研究:通俗易懂的总结。
Neurodegener Dis Manag. 2023 Dec;13(6):303-313. doi: 10.2217/nmt-2023-0012. Epub 2023 Sep 6.
10
Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水患者阿尔茨海默病脑脊液生物标志物的两点动态观察。
J Alzheimers Dis. 2019;72(1):271-277. doi: 10.3233/JAD-190775.

引用本文的文献

1
The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care.阿尔茨海默病协会关于疑似阿尔茨海默病及相关疾病的诊断评估、检测、咨询与信息披露的临床实践指南(DETeCD - ADRD):专科护理建议执行摘要
Alzheimers Dement. 2025 Jan;21(1):e14337. doi: 10.1002/alz.14337. Epub 2024 Dec 23.